AC
MRK icon

AlphaCore Capital’s Merck MRK Stock Holding History

AlphaCore Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.63M Buy
51,249
+2,383
+5% +$279K 0.12% 148
2026
Q1 		$5.92M Sell
48,866
-6,488
-12% -$749K 0.14% 132
2025
Q4 		$5.87M Buy
55,354
+17,728
+47% +$1.66M 0.13% 144
2025
Q3 		$3.19M Buy
37,626
+2,423
+7% +$200K 0.11% 149
2025
Q2 		$2.81M Buy
35,203
+8,062
+30% +$641K 0.11% 151
2025
Q1 		$2.46M Buy
27,141
+3,402
+14% +$318K 0.21% 100
2024
Q4 		$2.38M Sell
23,739
-5,561
-19% -$573K 0.51% 37
2024
Q3 		$3.35M Buy
29,300
+1,281
+5% +$152K 0.76% 23
2024
Q2 		$3.49M Buy
28,019
+2,128
+8% +$274K 0.84% 21
2024
Q1 		$3.44M Buy
25,891
+157
+0.6% +$19.4K 0.91% 22
2023
Q4 		$2.83M Buy
25,734
+222
+0.9% +$23K 0.41% 46
2023
Q3 		$2.64M Buy
25,512
+1,330
+5% +$143K 0.42% 50
2023
Q2 		$2.81M Buy
24,182
+9,649
+66% +$1.1M 0.45% 45
2023
Q1 		$1.55M Buy
14,533
+2,288
+19% +$247K 0.41% 38
2022
Q4 		$1.36M Buy
12,245
+2,799
+30% +$286K 0.53% 24
2022
Q3 		$813K Buy
9,446
+2,754
+41% +$246K 0.37% 30
2022
Q2 		$610K Buy
6,692
+1,616
+32% +$143K 0.28% 39
2022
Q1 		$416K Buy
+5,076
New +$400K 0.16% 49
2020
Q2 		– Sell
-1,660
Closed -$122K – 215
2020
Q1 		$122K Buy
+1,660
New +$130K 0.1% 66

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AlphaCore Capital's MRK Position: Q2 2026 in Review

AlphaCore Capital increased its Merck (MRK) stake by 4.9% in Q2 2026, buying an estimated $279K and bringing the position to 51,249 shares worth $6.63M. The position accounts for 0.12% of the portfolio, ranked #148.

AlphaCore Capital first reported a position in MRK in Q1 2020 and has held it in 19 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • AlphaCore Capital held 51,249 shares of Merck worth $6.63M as of Q2 2026.
  • AlphaCore Capital bought 2,383 Merck shares in Q2 2026, an estimated $279K.
  • Merck made up 0.12% of AlphaCore Capital's portfolio in Q2 2026, its #148 holding.
  • AlphaCore Capital first reported a position in Merck in Q1 2020 and has held it in 19 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.